Table 2. Statistically significant trends identified for compounds identified by VOC head space analysis for samples collected pre-challenge and 5 months post-challenge across all within treatment group comparisons.
| Vaccination Status | |||||
|---|---|---|---|---|---|
| Non-vaccinated | Vaccinated | Non-vaccinated | Non-vaccinated | ||
| Sex | |||||
| Compound | Retention Time (min) | Male (n = 4) | Male (n = 4) | Female (n = 3) | Mixed (n = 7) |
| Methylbenzene | 3.9 | Increased | Increased | Increased | |
| Hexanal | 4.5 | Decreased | Decreased | ||
| 2-Methyl pyridine | 4.9 | Decreased | Decreased | ||
| 2,4-Dimethyl pyridine | 5.5 | Increased | |||
| 2-(1,1-Dimethoxy)-ethanol | 10.8 | Decreased | |||
| 2-Ethyl-1-hexanol | 11.4 | Decreased | |||
| Benzene acetaldehyde | 11.8 | Decreased | |||
| 3,7-Dimethyl-6-octenyl-(2E)-2-butanoate | 12.1 | Increased | Decreased | ||
| Acetophenone | 12.5 | Decreased | |||
| 4-Methyl-phenol | 12.8 | Decreased | Increased | ||
| 2-Decanone | 15.6 | Increased | |||
| (-)-Beta-Fenchol | 16.7 | Decreased | |||
| 1-Decanol | 18.9 | Decreased | |||
| Indole | 19.4 | Increased | |||
| 3-(1,1-dimethylethyl)-4-methoxy-phenol | 24.0 | Decreased | Decreased | ||
| 1-Octadecanol | 29.6 | Increased | Increased | Increased | |
| 2-Dodecanone | 31.5 | Decreased | |||